India's Caplin Point rises on US FDA nod to unit for muscle relaxation drug

Caplin Point Laboratories

03/03/2023 06:32

** Shares of Caplin Point Laboratories  CAPL.NS  rise as
much as 2.77%, most intraday gain in a month, to 674 rupees
    ** Co says unit Caplin Steriles gets U.S. Food and Drug
Administration (USFDA) approval for drug used to provide muscle
relaxation during surgery
    ** USFDA approves Rocuronium Bromide Injection, which is
used as a neuromuscular blocking agent
    ** Injection had sales of $53 mln in the U.S. in the
12-month period ending September 2022
    ** About 35,000 shares of the pharma firm change hands as of
11:50 a.m. IST, 0.8x the 30-day avg - Refinitiv data



 (Reporting by Bharath Rajeswaran in Bengaluru)
 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463))